Testing

The strategic plan focuses on preventing new HIV infections in order to maintain a low HIV prevalence in the next six years. The NSP aims to reduce new HIV infections by 50% by 2020; intensify the provision of quality and accessible HIV prevention information and services for key populations; and also accelerate actions to eliminate mother-to-child transmission of HIV by 2020, including placing positive mothers on lifelong antiretroviral therapy (Option B+) as the preferred regime of treatment for HIV positive pregnant women.

Kenya AIDS Strategic Framework 2014/15-2018/19

Appel pour l’accélération de l’élimination de la transmission mère-enfant du VIH et le traitement antirétroviral chez l’enfant en Afrique de l’ouest et du centre d’ici 2020

Call for the acceleration of the elimination of mother-to-child HIV transmission and antiretroviral treatment for children in West and Central Africa by 2020

This diagram outlines the process to test infants exposed to HIV at birth in Cameroon.

In 2014, only 50% of all HIV-exposed infants were tested by the second month of age. Innovative approaches such as use of assays at the point-of care and adding virological testing at birth could speed up identification and ART initiation. Operational research to fully inform how to implement such innovations remains critical.